Literature DB >> 29100040

Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein.

Michelle C Silva1, Katie E Bryan1, Milagros D Morrical1, April M Averill2, Julie Dragon3, Adrian P Wiegmans4, Scott W Morrical5.   

Abstract

The human RAD51 recombinase possesses DNA pairing and strand exchange activities that are essential for the error-free, homology-directed repair of DNA double-strand breaks. The recombination activities of RAD51 are activated upon its assembly into presynaptic filaments on single-stranded DNA at resected DSB ends. Defects in filament assembly caused by mutations in RAD51 or its regulators such as BRCA2 are associated with human cancer. Here we describe two novel RAD51 missense variants located in the multimerization/BRCA2 binding region of RAD51. F86L is a breast tumor-derived somatic variant that affects the interface between adjacent RAD51 protomers in the presynaptic filament. E258A is a germline variant that maps to the interface region between the N-terminal and RecA homology domains of RAD51. Both variants exhibit abnormal biochemistry including altered DNA strand exchange activity. Both variants inhibit the DNA strand exchange activity of wild-type RAD51, suggesting a mechanism for negative dominance. The inhibitory effect of F86L on wild-type RAD51 is surprising since F86L alone exhibits robust DNA strand exchange activity. Our findings indicate that even DNA strand exchange-proficient variants can have negative functional interactions with wild-type RAD51. Thus heterozygous F86L or E258 mutations in RAD51 could promote genomic instability, and thereby contribute to tumor progression.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Homology-directed repair; Presynaptic filament; RAD51; Recombination; Variant

Mesh:

Substances:

Year:  2017        PMID: 29100040      PMCID: PMC5699509          DOI: 10.1016/j.dnarep.2017.10.008

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  43 in total

1.  Thermofluor-based high-throughput stability optimization of proteins for structural studies.

Authors:  Ulrika B Ericsson; B Martin Hallberg; George T Detitta; Niek Dekker; Pär Nordlund
Journal:  Anal Biochem       Date:  2006-08-10       Impact factor: 3.365

Review 2.  DNA-pairing and annealing processes in homologous recombination and homology-directed repair.

Authors:  Scott W Morrical
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-02-02       Impact factor: 10.005

3.  Identification of Rad51 alteration in patients with bilateral breast cancer.

Authors:  M Kato; K Yano; F Matsuo; H Saito; T Katagiri; H Kurumizaka; M Yoshimoto; F Kasumi; F Akiyama; G Sakamoto; H Nagawa; Y Nakamura; Y Miki
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.

Authors:  S J Collis; A Tighe; S D Scott; S A Roberts; J H Hendry; G P Margison
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

6.  Insights into the mechanism of Rad51 recombinase from the structure and properties of a filament interface mutant.

Authors:  Jianhong Chen; Nicolas Villanueva; Mark A Rould; Scott W Morrical
Journal:  Nucleic Acids Res       Date:  2010-04-05       Impact factor: 16.971

7.  A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.

Authors:  Anderson T Wang; Taeho Kim; John E Wagner; Brooke A Conti; Francis P Lach; Athena L Huang; Henrik Molina; Erica M Sanborn; Heather Zierhut; Belinda K Cornes; Avinash Abhyankar; Carrie Sougnez; Stacey B Gabriel; Arleen D Auerbach; Stephen C Kowalczykowski; Agata Smogorzewska
Journal:  Mol Cell       Date:  2015-08-06       Impact factor: 17.970

8.  BRCA2 BRC motifs bind RAD51-DNA filaments.

Authors:  Vitold E Galkin; Fumiko Esashi; Xiong Yu; Shixin Yang; Stephen C West; Edward H Egelman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.

Authors:  Najim Ameziane; Patrick May; Anneke Haitjema; Henri J van de Vrugt; Sari E van Rossum-Fikkert; Dejan Ristic; Gareth J Williams; Jesper Balk; Davy Rockx; Hong Li; Martin A Rooimans; Anneke B Oostra; Eunike Velleuer; Ralf Dietrich; Onno B Bleijerveld; A F Maarten Altelaar; Hanne Meijers-Heijboer; Hans Joenje; Gustavo Glusman; Jared Roach; Leroy Hood; David Galas; Claire Wyman; Rudi Balling; Johan den Dunnen; Johan P de Winter; Roland Kanaar; Richard Gelinas; Josephine C Dorsman
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

View more
  4 in total

1.  Germline BRCA2 Truncating Mutation in Familial Esophageal Squamous Cell Carcinoma: A Case Controlled Study in China.

Authors:  Zhong Liang; Weidong Hu; Shuping Li; Zhenhong Wei; Zijiang Zhu
Journal:  Med Sci Monit       Date:  2020-06-24

Review 2.  Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.

Authors:  Negesse Mekonnen; Hobin Yang; Young Kee Shin
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 3.  Variation in RAD51 details a hub of functions: opportunities to advance cancer diagnosis and therapy.

Authors:  Nick Ll van der Zon; Roland Kanaar; Claire Wyman
Journal:  F1000Res       Date:  2018-09-12

4.  Regulation and pharmacological targeting of RAD51 in cancer.

Authors:  McKenzie K Grundy; Ronald J Buckanovich; Kara A Bernstein
Journal:  NAR Cancer       Date:  2020-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.